Genetic Susceptibility to Listeriosis
- Conditions
- Listeriosis
- Interventions
- Procedure: Human biological samples
- Registration Number
- NCT03357536
- Lead Sponsor
- Institut Pasteur
- Brief Summary
Listeriosis is a rare, severe foodborne infection, responsible for severe invasive infections. It occurs in the great majority of cases in elderly patients and / or patients with comorbidities, with a deficit of innate or cellular immunity. Pregnancy is also a risk factor.
The Multicentric Observational NAtional Analysis of Listeriosis and Listeria (MONALISA) is an ongoing national case-control prospective study on listeriosis implemented since 2009 to study risk and prognosis factors for listeriosis. In this cohort, which enrolled 902 patients on 1 August 2014, 7% of patients with neurolisteriosis are under 40 years of age and have no identified risk factor. Genetic susceptibility is suspected in these patients. Genetic susceptibility could also explain the inconstant development of a neurolisteriosis or fetal infection, as well as the particular severity of some infections (death, foetal loss, neurological sequelae).
The aim of the study is to identify genetic susceptibility to Listeriosis.
- Detailed Description
Listeriosis is a rare, severe foodborne infection caused by the bacterium Listeria monocytogenes (Lm), responsible for severe invasive infections. It occurs in the great majority of cases in elderly patients and / or patients with comorbidities, with a deficit of innate or cellular immunity. Pregnancy is also a risk factor.
The Multicentric Observational NAtional Analysis of Listeriosis and Listeria (MONALISA) is an ongoing national case-control prospective study on listeriosis implemented since 2009 to study risk and prognosis factors for listeriosis. In this cohort, which enrolled 902 patients on 1 August 2014, 7% of patients with neurolisteriosis are under 40 years of age and have no identified risk factor. Genetic susceptibility is suspected in these patients. Genetic susceptibility could also explain the inconstant development of a neurolisteriosis or fetal infection, as well as the particular severity of some infections (death, foetal loss, neurological sequelae).
The analysis of the genetically transmitted vulnerability of Lm has not yet been studied, because of the lack of accessibility to prospective cohorts (and their DNA) for this rare and severe infection.
The aim of the study is to identify genetic susceptibility to Listeriosis that will optimize the patient care in terms of treatment and prevention.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 100
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Patients with Listeriosis Human biological samples Patients with Listeriosis. Human biological samples : * Blood sample * Skin biopsy * Saliva Volunteers related with patients with Listeriosis Human biological samples Volunteers related with patients with Listeriosis. Human biological samples : * Blood sample * Skin biopsy * Saliva
- Primary Outcome Measures
Name Time Method Identification of a susceptibility factor associated with Listeriosis infection 10 years In patients with Listeriosis, the hypothesis that the identified genetic variation is the mutation responsible for the infection will be verified :
* by verifying that it is not a listed polymorphism by sequencing genomic DNA controls
* by verifiyng that family genetic segregation is compatible with clinical segregation
* by verifying the function of the mutated protein in the patient's cell lines and / or fresh cells
* by performing complementation experiments by transfecting the wild-type allele into the patient's cells
- Secondary Outcome Measures
Name Time Method Identification of a susceptibility factor associated with the most severe or atypical forms 10 years In patients with Listeriosis, the susceptibility factor associated with the most severe or atypical forms will be characterized :
* By testing the response and production of cytokines involved in infection control.
* By identifying chromosomal regions associated with the disease by a homozygosity mapping genetic study on multiplex and / or inbred families.
* By sequencing the identified candidate genes.
Trial Locations
- Locations (1)
Centre Médical de l'Institut Pasteur
🇫🇷Paris, France